Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR0410 for Pain Management After Orthopaedic Surgery
NCT05394402Phase 2Terminated
- Sponsor
- Hengrui
- Start
- Aug 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of riminkefon in postoperative pain (3 arms), sponsored by Hengrui. Primary endpoint: Usage of Morphine, Post Surgery. Started Aug 2022; status: terminated.
02
Drugs
riminkefon
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05394402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05394402.